Does FILGRASTIM-SNDZ Cause Product packaging quantity issue? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product packaging quantity issue have been filed in association with FILGRASTIM-SNDZ. This represents 0.4% of all adverse event reports for FILGRASTIM-SNDZ.
6
Reports of Product packaging quantity issue with FILGRASTIM-SNDZ
0.4%
of all FILGRASTIM-SNDZ reports
1
Deaths
1
Hospitalizations
How Dangerous Is Product packaging quantity issue From FILGRASTIM-SNDZ?
Of the 6 reports, 1 (16.7%) resulted in death, 1 (16.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGRASTIM-SNDZ. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does FILGRASTIM-SNDZ Cause?
Death (505)
White blood cell count decreased (79)
Hospitalisation (68)
Neoplasm malignant (62)
Bone pain (61)
Pain (39)
Malaise (38)
Pyrexia (38)
Fatigue (37)
Drug ineffective (32)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which FILGRASTIM-SNDZ Alternatives Have Lower Product packaging quantity issue Risk?
FILGRASTIM-SNDZ vs FINASTERIDE
FILGRASTIM-SNDZ vs FINASTERIDE\TAMSULOSIN
FILGRASTIM-SNDZ vs FINERENONE
FILGRASTIM-SNDZ vs FINGOLIMOD
FILGRASTIM-SNDZ vs FINGOLIMOD LAURYL